![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
RV Benya, Z Fathi, T Kusui, T Pradhan, JF Battey and RT Jensen
Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.
Stimulation of the gastrin-releasing peptide receptor (GRP-R) in Swiss 3T3 cells resembles that of a number of other recently described G protein-coupled receptors, insofar as both the phospholipase C and adenylyl cyclase signal transduction pathways are activated. GRP-R activation induces numerous alterations in both the cell and the receptor, but because two signal transduction pathways are activated it is difficult to determine the specific contributions of either pathway. We have found that BALB/3T3 fibroblasts transfected with the coding sequence for the GRP-R are pharmacologically indistinguishable from native receptor-expressing cells and activate phospholipase C in a manner similar to that of the native receptor but fail to increase cAMP in response to bombesin; thus, they may be useful cells to explore the role of activation of each pathway in altering cell and receptor function. Swiss 3T3 cells and GRP-R-transfected BALB/3T3 cells expressed identically glycosylated receptors that bound various agonists and antagonists similarly. G protein activation, as determined by evaluation of agonist-induced activation of phospholipase C and by analysis of the effect of guanosine-5'-(beta,gamma-imido)triphosphate on GRP-R binding affinity, was indistinguishable. Agonist stimulation of GRP-R caused similar receptor changes (internalization and down- regulation) and homologous desensitization in both cell types. Bombesin stimulation of Swiss 3T3 cells that had been preincubated with forskolin increased cAMP levels 9-fold, but no bombesin-specific increase in cAMP levels was detected in transfected cells, even though forskolin and cholera toxin increased cAMP levels in these cells. Quiescent Swiss 3T3 cells treated with bombesin rapidly increased c-fos mRNA levels and [3H]thymidine incorporation, whereas both effects were potentiated by forskolin. The specific protein kinase A inhibitor H-89 blocked increases in c-fos levels and [3H]thymidine incorporation induced by low concentrations of bombesin. GRP-R-transfected BALB/3T3 cells increased c-fos mRNA levels and [3H]thymidine incorporation with the addition of serum but not bombesin. These data suggest that bombesin-stimulated increases in cellular levels of cAMP appear not to be an important mediator of GRP-R internalization, down-regulation, or desensitization but do play an important role in bombesin-induced mitogenesis.
This article has been cited by other articles:
|
|
 |
|
  R. T. Jensen, J. F. Battey, E. R. Spindel, and R. V. Benya International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States Pharmacol. Rev., March 1, 2008; 60(1): 1 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Mantey, N. Gonzalez, M. Schumann, T. K. Pradhan, L. Shen, D. H. Coy, and R. T. Jensen Identification of Bombesin Receptor Subtype-Specific Ligands: Effect of N-Methyl Scanning, Truncation, Substitution, and Evaluation of Putative Reported Selective Ligands J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 980 - 989. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Igarashi, T. Ito, S. A. Mantey, T. K. Pradhan, W. Hou, D. H. Coy, and R. T. Jensen Development of Simplified Vasoactive Intestinal Peptide Analogs with Receptor Selectivity and Stability for Human Vasoactive Intestinal Peptide/Pituitary Adenylate Cyclase-Activating Polypeptide Receptors J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 370 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Mantey, D. H. Coy, L. K. Entsuah, and R. T. Jensen Development of Bombesin Analogs with Conformationally Restricted Amino Acid Substitutions with Enhanced Selectivity for the Orphan Receptor Human Bombesin Receptor Subtype 3 J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1161 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W. Moody, S. A. Mantey, T. K. Pradhan, M. Schumann, T. Nakagawa, A. Martinez, J. Fuselier, D. H. Coy, and R. T. Jensen Development of High Affinity Camptothecin-Bombesin Conjugates That Have Targeted Cytotoxicity for Bombesin Receptor-containing Tumor Cells J. Biol. Chem., May 28, 2004; 279(22): 23580 - 23589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schumann, T. Nakagawa, S. A. Mantey, K. Tokita, D. J. Venzon, S. J. Hocart, R. V. Benya, and R. T. Jensen Importance of Amino Acids of the Central Portion of the Second Intracellular Loop of the Gastrin-Releasing Peptide Receptor for Phospholipase C Activation, Internalization, and Chronic Down-Regulation J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 597 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Igarashi, T. Ito, T. K. Pradhan, S. A. Mantey, W. Hou, D. H. Coy, and R. T. Jensen Elucidation of the Vasoactive Intestinal Peptide Pharmacophore for VPAC2 Receptors in Human and Rat and Comparison to the Pharmacophore for VPAC1 Receptors J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 445 - 460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Bajo, A. V. Schally, M. Krupa, F. Hebert, K. Groot, and K. Szepeshazi Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes PNAS, March 19, 2002; 99(6): 3836 - 3841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. V. Benya, T. Kusui, T. Katsuno, T. Tsuda, S. A. Mantey, J. F. Battey, and R. T. Jensen Glycosylation of the Gastrin-Releasing Peptide Receptor and Its Effect on Expression, G Protein Coupling, and Receptor Modulatory Processes Mol. Pharmacol., April 13, 2001; 58(6): 1490 - 1501. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. J. Kim, B. M. Evers, D. A. Litvak, M. R. Hellmich, and C. M. Townsend Jr. Signaling mechanisms regulating bombesin-mediated AP-1 gene induction in the human gastric cancer SIIA Am J Physiol Cell Physiol, August 1, 2000; 279(2): C326 - C334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Ryan, T. Katsuno, S. A. Mantey, T. K. Pradhan, H. C. Weber, D. H. Coy, J. F. Battey, and R. T. Jensen Comparative Pharmacology of the Nonpeptide Neuromedin B Receptor Antagonist PD 168368 J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1202 - 1211. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. C. Saurin, E. Nemoz-Gaillard, B. Sordat, J. C. Cuber, D. H. Coy, J. Abello, and J. A. Chayvialle Bombesin Stimulates Adhesion, Spreading, Lamellipodia Formation, and Proliferation in the Human Colon Carcinoma Isreco1 Cell Line Cancer Res., February 1, 1999; 59(4): 962 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Ryan, H. C. Weber, S. A. Mantey, W. Hou, M. E. Hilburger, T. K. Pradhan, D. H. Coy, and R. T. Jensen Pharmacology and Intracellular Signaling Mechanisms of the Native Human Orphan Receptor BRS-3 in Lung Cancer Cells J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 366 - 380. [Abstract] [Full Text]
|
|
|
|
|
|
E. Sainz, M. Akeson, S. A. Mantey, R. T. Jensen, and J. F. Battey Four Amino Acid Residues Are Critical for High Affinity Binding of Neuromedin B to the Neuromedin B Receptor J. Biol. Chem., June 26, 1998; 273(26): 15927 - 15932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Ryan, H. C. Weber, W. Hou, E. Sainz, S. A. Mantey, J. F. Battey, D. H. Coy, and R. T. Jensen Ability of Various Bombesin Receptor Agonists and Antagonists to Alter Intracellular Signaling of the Human Orphan Receptor BRS-3 J. Biol. Chem., May 29, 1998; 273(22): 13613 - 13624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Mantey, H. C. Weber, E. Sainz, M. Akeson, R. R. Ryan, T. K. Pradhan, R. P. Searles, E. R. Spindel, J. F. Battey, D. H. Coy, et al. Discovery of a High Affinity Radioligand for the Human Orphan Receptor, Bombesin Receptor Subtype 3, Which Demonstrates That It Has a Unique Pharmacology Compared with Other Mammalian Bombesin Receptors J. Biol. Chem., October 10, 1997; 272(41): 26062 - 26071. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Allen, S. D. Rogers, J. R. Ghilardi, P. M. Menning, M. A. Kuskowski, A. I. Basbaum, D. A. Simone, and P. W. Mantyh Noxious Cutaneous Thermal Stimuli Induce a Graded Release of Endogenous Substance P in the Spinal Cord: Imaging Peptide Action In Vivo J. Neurosci., August 1, 1997; 17(15): 5921 - 5927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tsuda, T. Kusui, W. Hou, R. V. Benya, M. A. Akeson, G. S. Kroog, J. F. Battey, and R. T. Jensen Effect of Gastrin-Releasing Peptide Receptor Number on Receptor Affinity, Coupling, Degradation, and Modulation Mol. Pharmacol., May 1, 1997; 51(5): 721 - 732. [Abstract] [Full Text]
|
|
|
|
|
|
M. R. Hellmich, J. F. Battey, and J. K. Northup Selective reconstitution of gastrin-releasing peptide receptor with Galpha q PNAS, January 21, 1997; 94(2): 751 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Corcoran and W. G. Stetler-Stevenson Tissue Inhibitor of Metalloproteinase-2 Stimulates Fibroblast Proliferation via a cAMP-dependent Mechanism J. Biol. Chem., June 2, 1995; 270(22): 13453 - 13459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. V. Benya, T. Kusui, J. F. Battey, and R. T. Jensen Chronic Desensitization and Down-regulation of the Gastrin-releasing Peptide Receptor Are Mediated by a Protein Kinase C-dependent Mechanism J. Biol. Chem., February 17, 1995; 270(7): 3346 - 3352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tokita, S. J. Hocart, T. Katsuno, S. A. Mantey, D. H. Coy, and R. T. Jensen Tyrosine 220 in the 5th Transmembrane Domain of the Neuromedin B Receptor Is Critical for the High Selectivity of the Peptoid Antagonist PD168368 J. Biol. Chem., January 5, 2001; 276(1): 495 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Mantey, D. H. Coy, T. K. Pradhan, H. Igarashi, I. M. Rizo, L. Shen, W. Hou, S. J. Hocart, and R. T. Jensen Rational Design of a Peptide Agonist That Interacts Selectively with the Orphan Receptor, Bombesin Receptor Subtype 3 J. Biol. Chem., March 16, 2001; 276(12): 9219 - 9229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tokita, T. Katsuno, S. J. Hocart, D. H. Coy, M. Llinares, J. Martinez, and R. T. Jensen Molecular Basis for Selectivity of High Affinity Peptide Antagonists for the Gastrin-releasing Peptide Receptor J. Biol. Chem., September 21, 2001; 276(39): 36652 - 36663. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
